Hale David F
SEC-identified person · CIK 1024004 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Dermata Therapeutics, Inc. DRMA | Director | filed 2021 - 2026 |
| Oncternal Therapeutics, Inc. ONCT | Director | filed 2019 - 2024 |
| Biocept INC BIOC | Director · EXECUTIVE CHAIRMAN | filed 2014 - 2021 |
| Histogen Inc. HSTO | Director | filed 2013 - 2019 |
| Santarus INC SNTS | Director | filed 2006 - 2014 |
| Somaxon Pharmaceuticals, Inc. somx | Director · Interim CEO & Executive Chmn | filed 2006 - 2013 |
| Micromet, INC. MITI | Director · President and CEO | filed 2006 - 2012 |
| Metabasis Therapeutics INC MBRX | Director | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.